Verve Therapeutics, Inc. (VERV) Other Liabilities, Noncurrent USD 2020 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary: Verve Therapeutics, Inc. quarterly Other Liabilities, Noncurrent history and growth rate from 2020 to 2024.
Verve Therapeutics, Inc. Other Liabilities, Noncurrent for the quarter ending March 31, 2024 was $165K, a 36.5% decline year-over-year.

Other Liabilities, Noncurrent, Quarterly Data (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2024	$165K	-$95K	-36.5%	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$189K	-$94K	-33.2%	Dec 31, 2023	10-Q	2024-05-08
Q3 2023	$213K			Sep 30, 2023	10-Q	2023-11-07
Q2 2023	$236K			Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$260K			Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$283K	-$94K	-24.9%	Dec 31, 2022	10-K	2024-02-27
Q4 2021	$377K	+$377K		Dec 31, 2021	10-K	2023-03-02
Q4 2020	$0			Dec 31, 2020	10-K	2022-03-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.